A regenerative medicine timeline in three phases — repair, rebuild and remodel — what each month is doing, and why the last one decides durable function.
The three-month arc tends to be sold as a schedule. It is better understood as a sequence of biological jobs that have to happen in order, each taking roughly a month in a straightforward case and considerably longer in a complicated one.
The order is not a marketing device. You cannot lay down new matrix in an environment inflamed enough to degrade it as fast as it appears, and you cannot organise matrix that has not been built yet. Skip a stage and the stage after it fails quietly.
What follows is the arc as we describe it to patients — repair, rebuild, remodel, and then the part nobody puts on a poster. It assumes you already know roughly what regenerative signaling factors are; if not, start there and come back.
First the environment has to stop working against you. Signalling factors are used to support immune balance so that inflammation can resolve rather than idle, while barrier tissue seals: tighter junctions in skin and mucosa. Usually paired with H₂ inhalation.
With the noise down, tissue can lay down new matrix. Cell-free factors from all six placental regions carry the construction cues — collagen deposition, basement-membrane integrity, and the microcirculation that has to feed both.
New tissue is not finished tissue. Collagen I/III balance and fiber organisation decide whether function actually returns, and a maintenance rhythm is what holds whatever was gained.
Chronic problems usually sit inside a chemical environment that keeps re-injuring the thing trying to heal. Oxidative pressure runs high, inflammation never quite resolves, barrier tissue leaks. Anything constructive attempted in that state is partly dismantled as it is built.
So the first month is subtractive in spirit. Ultra RSF (Regenerative Signaling Factors) is used for its immune-balance and barrier signalling, typically alongside molecular hydrogen, which is understood to preferentially neutralise the harshest oxidants such as the hydroxyl radical while leaving the milder reactive species the body uses for ordinary signalling largely alone. Why that selectivity matters is a subject in its own right.
This is also the month when patients most often notice something, which is worth flagging early because it misleads people. Comfort, sleep and mental clarity tend to shift first. None of that is evidence that structural repair has occurred; it is evidence that the environment changed.
Once inflammation is resolving rather than idling, constructive work becomes possible. This is where the acellular concentrate does most of its notional work: over 300 proteins and growth factors drawn from six distinct placental regions, carrying instructions associated with collagen deposition and basement-membrane integrity.
Construction also needs delivery. New matrix without perfusion is a wall built where nobody can bring bricks, which is why microcirculation and mitochondrial support belong in the same month as collagen. Lower oxidative pressure inside the cell is associated with steadier ATP, and repair is metabolically expensive.
One thing bears repeating here more than anywhere else in the arc: Ultra RSF is not a stem-cell therapy. It is acellular, DNA-free and RNA-free, and nothing in the vial becomes your tissue. Your own cells do all of the building, which is precisely why age, nutrition and load tolerance change what month two produces. The composition comparison with stem cells and exosomes has the detail.
Remodelling is unglamorous, and it is where the outcome is genuinely determined. Newly deposited collagen is disorganised and mechanically poor. Over the following weeks it is cross-linked, reoriented along the lines it is loaded through, and the ratio of collagen III to collagen I shifts as the tissue matures.
Fiber organisation is the difference between tissue that is present and tissue that works. A joint packed with disordered matrix can feel considerably better and still fail the first time it is properly loaded, which is why the third month involves less novelty and more consistency than patients expect.
Most people stop in month three, because month three is when they feel well. That is exactly the month deciding whether they stay that way.
Load matters here too. Gentle, progressive use is part of remodelling rather than a reward for having completed it, and the physiotherapist or physician directing your rehabilitation should be the one setting that side of the schedule.
Nothing in this arc changes the underlying tendency that produced the problem. A knee with years of mechanical history still has that history. An inflammatory condition still has whatever drives it. Remodelling ends; the load and the biology carry on.
Which is why a starter course is followed by a maintenance rhythm rather than a finish line. For hydrogen inhalation the starter course is commonly four to six weeks at two or three sessions a week, 20 to 40 minutes each, after which the physician sets a maintenance schedule against how you are actually doing. Tracking is the point of the fourth stage of care: a plan that is monitored and adjusted rather than simply repeated.
The arc described here runs roughly three months across repair, rebuild and remodel phases, followed by a maintenance rhythm. Individual timelines vary with severity and with the condition being addressed.
Many patients notice changes in comfort, sleep or mental clarity within one to two weeks. For complex cases it is more realistic to plan on four to eight weeks before any trend line is clear.
Newly deposited collagen is disorganised and mechanically weak. Remodeling is where fibers reorient and mature, which is what determines whether returned function is durable rather than temporary.
A maintenance rhythm set by the physician, with tracking so the plan can be adjusted. Nothing about the arc removes the underlying tendency that produced the problem in the first place.
Feeling better and finishing remodeling are not the same milestone. That is a decision to make with the physician directing your plan rather than on your own.
This article is general health information, not medical advice, and does not create a physician–patient relationship. It describes mechanisms reported in the literature rather than guaranteed outcomes; individual response varies. Regen MDs provides you an alternative to your current care, and is complementary to your guideline-based medical care. Ultra RSF (Regenerative Signaling Factors) is not a stem-cell therapy. Talk to a licensed clinician before starting, stopping, or changing any treatment.
The reason so much regenerative research points away from the cells themselves, and what a physician is actually giving when the vial says signaling factors.
A stage-by-stage account of the first call — who is on it, what gets decided later, and the cases we turn away.
The consultation happens on a screen, the equipment arrives in a box, and the follow-up is remote. What that model covers, and what it does not.
Thirty minutes with one of our physicians — no cost, no obligation — to review your history and set out the options honestly.